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Abstract
Introduction Cocoa flavanols (CF) may exert health benefits through their potent vasodilatory effects, which are perpetuated 
by elevations in nitric oxide (NO) bioavailability. These vasodilatory effects may contribute to improved delivery of blood 
and oxygen  (O2) to exercising muscle.
Purpose Therefore, the objective of this study was to examine how CF supplementation impacts pulmonary  O2 uptake ( V̇O2 ) 
kinetics and exercise tolerance in sedentary middle-aged adults.
Methods We employed a double-blind cross-over, placebo-controlled design whereby 17 participants (11 male, 6 female; 
mean ± SD, 45 ± 6 years) randomly received either 7 days of daily CF (400 mg) or placebo (PL) supplementation. On day 7, 
participants completed a series of ‘step’ moderate- and severe-intensity exercise tests for the determination of V̇O
2
 kinetics.
Results During moderate-intensity exercise, the time constant of the phase II V̇O
2
 kinetics ( 𝜏V̇O
2
 ) was decreased by 15% 





 ; PL 0.77 ± 0.32 l  min−1 vs. CF 0.79 ± 0.34 l  min−1, P = 0.263). However, during severe-intensity exercise, 𝜏V̇O
2
 , 
the amplitude of the slow component ( SCV̇O
2
 ) and exercise tolerance (PL 435 ± 58 s vs. CF 424 ± 47 s, P = 0.480) were 
unchanged between conditions.
Conclusion Our data show that acute CF supplementation enhanced V̇O
2
 kinetics during moderate-, but not severe-intensity 
exercise in middle-aged participants. These novel effects of CFs, in this demographic, may contribute to improved tolerance 
of moderate-activity physical activities, which appear commonly present in daily life.
Trial registration Registered under ClinicalTrials.gov Identifier no. NCT04370353, 30/04/20 retrospectively registered
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 contraction and force production form 
the basis for the ability to perform physical activity, both 
for daily life activities as well as during sports-related 
events. Repeated muscle contractions require continu-
ous regeneration of adenosine triphosphate (ATP). The 
production of ATP during (prolonged) physical activ-
ity is driven through the mechanism of oxidative phos-
phorylation, which depends on sufficient availability of 
oxygen  (O2) amongst other key substrates (Poole et al. 
2008). Impairment to pathways involved in the delivery 
of  O2 to working skeletal muscle, like that observed in 
older and physically inactive adults, leads to slower rates 
of pulmonary  O2 uptake ( V̇O2 ) and therefore greater  O2 
deficit (Cunningham and Paterson 1994; DeLorey et al. 
2004a; Dumanoir et al. 2010; Whipp and Rossiter 2013; 
George et al. 2018). Slower V̇O
2
 kinetics in response to 
physical activity are associated with lower exercise toler-
ance (Grassi et al. 2011; Goulding et al. 2017, 2018), and 
may affect the capacity to perform daily life activities that 
require moderate-intensity physical activity.
The slower dynamic adjustment of V̇O
2
 across a meta-
bolic transient observed in older adults is thought to be 
due to a mismatch of  O2 delivery to  O2 utilisation (Murias 
et al. 2010; Murias and Paterson 2015; George et al. 2018). 
Indeed, attenuations in microvascular blood flow supply 
and distribution (and thus  O2 delivery) within aged skel-
etal muscle are well documented (Muller-Delp et al. 2002; 
Musch et al. 2004; Behnke and Delp 2010; Dumanoir et al. 
2010). These reductions in  O2 delivery to active skeletal 
muscle are likely caused by impaired vascular endothelial 
function and diminished nitric oxide (NO) bioavailabil-
ity (Muller-Delp et al. 2002; Woodman et al. 2002; Spier 
et al. 2004; Sindler et al. 2009). Interestingly, lifestyle 
interventions, such as exercise training and dietary strate-
gies (Vanhatalo et al. 2010; Schreuder et al. 2015), have 
demonstrated potent effects to enhance NO bioavailability 
and improve endothelial function. Consequently, a number 
of studies have shown faster V̇O
2
 kinetics in concert with 
increased  O2 availability (Murias et al. 2010; Bailey et al. 
2015; Goulding et al. 2017).
Cocoa flavanols (CFs) represent a group of flavonoids 
present in cocoa derived from seeds of the fruit of the 
Theobroma cacao tree. Previous studies have found CFs 
(700–900 mg range) act primarily through the monomer 
(−)-epicatechin, to stimulate NO production, resulting in 
improved vasodilation and endothelial function in healthy 
adults (Schroeter et al. 2006; Davison et al. 2008; Berry 
et al. 2010). Given the direct impact of CFs on NO pro-
duction and vascular endothelial function, and the nega-
tive effects of sedentary ageing on  O2 delivery and V̇O2 
kinetics at the onset of exercise, our objective was to test 
the hypothesis that, compared with placebo (PL), CF sup-
plementation speeds phase II V̇O
2
 kinetics during moder-
ate-intensity physical activity and increases exercise toler-
ance in healthy middle-aged individuals.
Methodology
Participants
Seventeen healthy middle-aged adults (11 male: 
mean ± SD, age 45 ± 6 years; body mass 87.7 ± 13.5 kg; 
height 1.75 ± 0.07 m; and 6 female: aged 47 ± 5 years; 
body mass 68.2 ± 17.7 kg; height 1.62 ± 0.09 m) volun-
teered and gave written informed consent to participate 
in the study (see Fig. 1). All procedures conformed to 
the Declaration of Helsinki and were approved by Liver-
pool John Moores University Research Ethics Committee 
(approval reference number: 18/SPS/014). Participants 
engaged in less than two hours of structured exercise 
training per week. All participants were non-smokers and 
had no history of cardiovascular, respiratory or metabolic 
diseases. Participants were not taking any dietary supple-
ments or medication.
Participants reported to the laboratory at least 3 h post-
prandial in a rested state, having completed no strenuous 
exercise within the previous 24 h and avoided alcohol 
and caffeine for 24 and 6 h, preceding each exercise test, 
respectively. Participants were advised to avoid consump-
tion of flavonoid-rich foodstuffs (e.g. green tea, dark choc-
olate and berries) in the 24 h preceding each experimental 
trial.
Procedures
Participants visited the temperature-controlled laboratory 
(19–22 °C) on four occasions during a 4–5-week period, 
with each test scheduled at the same time of day (± 1 h) and 
at least 48 h between visits. Participants completed two pre-
liminary trials and two experimental trials. Exercise bouts 
were performed on an electrically operated cycle ergometer 
(Lode Corival, Groningen, The Netherlands). Saddle and 
handlebar height/angle were recorded at the first visit and 
replicated during each subsequent visit for each individual 
participant. Throughout all exercise tests, participants were 
instructed to maintain a cadence of 65–80 rev  min−1, and 
exhaustion was defined as when the participants cadence 
dropped 10 rev  min−1 below the target work rate. Time to 
exhaustion was measured to the nearest second (s) in all 
tests.
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Preliminary trial(s)
Upon arrival to the laboratory, participants’ height and 
weight were recorded. Subsequently, each participant under-
took an incremental step test until the limit of tolerance to 
establish V̇O
2
 peak, the gas exchange threshold (GET) and 
the power outputs for later tests. The incremental step test 
consisted of 3-min of baseline pedalling at 0 W, followed 
by a continuous, stepped increase in power output of 30 or 
25 W every minute (for males and females, respectively) 
until the limit of tolerance was established. Gas exchange 
and ventilatory variables were measured continuously at 
the mouth breath-by-breath throughout each test. V̇O
2
 peak 
was defined as the highest V̇O
2
 value obtained over 30 s. 
The GET was determined using a collection of previously 
established criteria (Beaver et al. 2016) including (1) a dis-
proportionate rise in  CO2 production ( V̇CO2 ) relative to 
V̇O
2












 ); and (3) an increase in end tidal  O2 tension 
without decreasing end tidal  CO2 tension.
During the familiarisation trial (visit 2), participants were 
requested to perform two bouts of severe-intensity exercise 
at a fixed power output to exhaustion (e.g.  Tlim), each sepa-
rated by 45 min of seated rest. The power outputs of these 
severe-intensity bouts were selected based upon perfor-
mance during the incremental test and were calculated to 
be 60% ∆ (i.e., a work rate calculated to require 60% of 
the difference between GET and V̇O
2
 peak). On occasion, 
adjustments were made to the power output of the subse-
quent exercise tests based upon performance in the famil-
iarisation trials; the prescribed power output was lowered for 
participants who failed to exercise for up to 360 s during the 
severe-intensity bouts.
After completion of the familiarisation trial, participants 
were randomly assigned (computer generated), using a dou-
ble-blind cross-over design (Fig. 2), to receive seven consec-
utive days of CF supplementation or a PL that was matched 
for caffeine and theobromine content. Nine participants 
began with the CF condition, and eight participants began 
with the PL condition. Participants were advised to con-
sume four capsules daily. Each CF capsule contained 316 mg 
CocoActiv (Naturex, Netherlands; ~ 100 mg total flavanols 
of which 22 mg DP1 = catechin + epicatechin) whereas PL 
capsules contained 0 mg CocoActiv product. This CF dose 
was selected based on the knowledge that ~ 400 mg CF’s 
Fig. 1  CONSORT diagram 
showing the flow of partici-
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are required to improve vascular function during exercise 
(Decroix et al. 2018a). Both PL and CF capsules contained 
2.9 mg caffeine and 22.5 mg theobromine (Fagron, Nether-
lands). Remaining empty volumes of PL and CF capsules 
were filled with microcrystalline cellulose (Fagron, Nether-
lands). Two capsules were taken in the morning and two in 
the evening following ingestion of a mixed meal (Cifuentes-
Gomez et al. 2015). A 7-day wash-out period separated the 
supplementation periods and the order between CF and PL 
supplementation was randomised. Throughout the study 
period participants were instructed to maintain their normal 
daily activities and diet. Participants kept a food dairy and 
were instructed to consume an identical diet in the two peri-
ods of exercise testing. Physical activity levels were meas-
ured by accelerometery in the 6 days preceding testing via a 
hip-mounted activity monitor (Actigraph GT3X).
Experimental trials
On the 7th day of supplementation, participants were 
advised to consume four capsules 45 min prior to arrival at 
the laboratory. The supplementation protocol was chosen so 
that participants commenced exercise testing ~ 90 min fol-
lowing supplement ingestion, which coincided with reported 
peak plasma flavanol concentrations (Cifuentes-Gomez 
et al. 2015). The participants completed a series of separate 
“step” exercise tests from an unloaded (0 W) baseline to 
moderate or severe-intensity work rates for the determina-
tion of pulmonary V̇O
2
 kinetics. Tests began with 3 min of 
0 W baseline cycling, before a step change in power output 
to 80% GET for 6 min or 60% ∆ until  Tlim. Participants 
sequentially completed three bouts of moderate- and one 
bout of severe-intensity exercise, each separated by 10 min 
of passive recovery. This protocol was employed with the 
knowledge that multiple bouts of moderate-intensity exercise 
do not impact the V̇O
2
 kinetics of subsequent moderate- and 
heavy-intensity exercise (Burnley et al. 2000; Spencer et al. 
2011).
Measurements
After arrival to the laboratory, participants underwent an 
assessment of the previous 7 days physical activity levels 
and sedentary behaviour by the International Physical Activ-
ity Questionnaire (IPAQ) and by accelerometery (ActiGraph 
GTX3) (data not shown). Following 10 min of seated rest, 
participants blood pressure was measured in the brachial 
artery. Blood pressure was measured three times and the 
mean of the responses was recorded.
During all exercise tests, pulmonary gas exchange and 
ventilation were measured at the mouth breath-by-breath 
using a metabolic cart (Jaeger Oxycon Pro, Hoechberg, Ger-
many). Participants wore a facemask and breathed through a 
low dead space (90 ml), low resistance (0.75 mmHg  l−1  s−1 
at 15 l/s) impeller turbine assembly (Jaeger Triple V, Hoe-
chberg, Germany). The inspired and expired gas volumes 
and gas concentration signals were continuously sampled 
at 100 Hz, the latter using paramagnetic  (O2) and infrared 
 (CO2) analysers (Jaeger Oxycon Pro, Hoechberg, Germany) 
via a capillary line connected to the mouthpiece. These ana-
lysers were calibrated before each test with gases of known 
concentrations (16%  O2 and 4%  CO2), and the turbine vol-
ume transducer was calibrated using a 3-L syringe (Hans 
Rudolph, Kansas City, MO). The volume and concentration 
signals were time aligned by accounting for the delay in 
capillary gas transit and analyser rise time relative to the vol-
ume signal. Breath-by-breath fluctuations in lung gas stores 
were corrected for by computer algorithms (Beaver et al. 
1981). Heart rate was measured during all tests via short-
range radiotelemetry (Polar H10, Polar Electro, Kempele, 
Finland). During one of the transitions to moderate- and 
severe-intensity exercise for both supplementation periods, 
a blood sample was collected from a fingertip over the last 
30 s preceding the step transition in work rate and within 
the last 15 s of exercise. Blood samples were immediately 
analysed using a hand-held device (Lactate Pro, Nova Bio-
medical, USA) to determine blood lactate concentration. 
Fig. 2  Schematic of experimen-
tal design
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Blood lactate accumulation was calculated as the difference 





 data were edited to remove data points 
lying more than three standard deviations (SD) outside the 
local 5-breath mean (Lamarra et al. 1987). The resultant 
data were then linearly interpolated to provide second-by-
second values. For V̇O
2
 and heart rate data in response to 
moderate exercise transitions, second-by-second data for the 
three transitions were averaged together to produce a single 
dataset. The severe-intensity exercise bout for each condi-
tion was not repeated and was modelled separately. For each 
exercise transition, the first 20 s of data after the onset of 
exercise (i.e., the cardiodynamic or phase I response) was 
deleted (McNarry et al. 2012; Benson et al. 2017) and a 
mono-exponential model (Eq. 1) with time delay was then 
fitted to the data (Whipp and Rossiter 2013), as follows:
where V̇O
2
(t) is the V̇O
2
 at any time t, V̇O
2b
 is the baseline 
V̇O
2
 , which was taken as the mean V̇O
2
 over the final 30 s 
of the baseline period preceding the transition, AV̇O
2
 is the 




the time delay of the primary response relative to the onset 
of exercise, and 𝜏V̇O
2
 is the time constant of the primary 
response. For moderate-intensity exercise, data were mod-
elled to 360 s. For severe-intensity exercise, the onset of 
the V̇O
2
slow component ( TD
SCV̇O
2
 ) was determined using 
purpose-designed programming in Microsoft Excel (Micro-
soft Corporation, Redmond, WA, USA), which iteratively 
fits a monoexponential function to the V̇O
2
 data, starting at 
60 s until the window encompasses the entire response. The 




 was identified as the point at which 𝜏V̇O
2
 
consistently deviates from a previously ‘flat’ profile, and the 
demonstration of a local threshold in the χ2 value (Rossiter 
et al. 2001). This method allows the fitting of Eq. (1) to 
the primary component of the response isolated from the 
slow component, thus avoiding the possibility of arbitrar-
ily parameterizing the slow component. The amplitude of 
the V̇O
2
 slow component was determined by calculating 
the difference between the end-exercise V̇O
2
 (i.e. mean V̇O
2
 




 ). In instances 
where exercise duration was too short to allow the slow com-
ponent to be discerned the V̇O
2
 response was modelled using 
Eq. (1) to the end of exercise and the slow component was 
assigned a value of 0.
Heart rate kinetics were modelled for each exercise tran-
sition using a monoexponential function (Eq. 2) with the 




response constrained to the start of exercise (at t = 0; i.e., 
with no time delay):
where  HRb is the mean HR measured over the final 30 s of 
baseline cycling, and AHR and τHR are the amplitude and 
the time constant of the response, respectively.
Statistics
Based on previous knowledge of a meaningful change in 
𝜏V̇O
2
 during intervention studies (5 s), and a common stand-
ard deviation of 4.3 s (Benson et al. 2017), the necessary 
calculated sample size was 12. Differences in the cardiores-
piratory variables between conditions were determined with 
two-tailed, paired-samples t tests (GraphPad, Prism, USA). 
Data are presented as means ± SD. Statistical significance 




 was 2.45 ± 0.61 l  min−1 (28.1 ± 5.7 ml  kg−1  min−1), 
with the mean GET occurring at 1.51 ± 0.46  l   min−1 
(108 ± 39 W). The peak work rate attained from the incre-
mental test was 207 ± 49 W and the work rates calculated 
to require 80% of the GET and 60% ∆ were 87 ± 29 W and 
166 ± 40 W, respectively.
Heart rate kinetics, blood lactate profiles and blood 
pressure
There were no differences in the primary τHR between PL 
and CF for moderate- or severe-intensity bouts (P = 0.219 
and 0.956, respectively, Table 1). Despite significant changes 
in blood lactate concentrations at  Tlim compared to baseline 
(P < 0.05; Table 1), there were no significant differences in 
blood (lactate) from pre- to post-exercise between conditions 
during moderate- and severe-intensity exercise (see Table 1). 
Overall, there were no differences between resting systolic 
(PL 128 ± 12 mmHg vs. CF 127 ± 12 mmHg, P = 0.66) or 
diastolic (PL 78 ± 7 mmHg vs. 78 ± 7 mmHg, P = 0.75) 
blood pressure following either PL or CF administration.
V̇O
2
 kinetics and exercise tolerance
The V̇O
2
 kinetic parameters for moderate-intensity exer-
cise are presented in Table 2, and the V̇O
2
 response of a 
representative participant to moderate-intensity exercise 
is shown in Fig. 3. Compared with PL, 𝜏V̇O
2
 was smaller 
during moderate-intensity exercise following CF sup-
plementation (PL 40 ± 12 s vs. CF 34 ± 9 s, P = 0.019). 




 European Journal of Applied Physiology
1 3
However, there were no differences in V̇O
2b
 (P = 0.175), 
AV̇O
2
 (P = 0.263), TDV̇O
2
 (P = 0.961) or end exercise V̇O
2
 
(P = 0.565) between PL and CF.
The pulmonary V̇O
2
 response to severe-intensity exer-
cise for a representative participant is shown in Fig. 4a and 
group mean responses are shown in Fig. 4b. The associated 
modelled parameters are presented in Table 2. No impact 
of CF supplementation on the 𝜏V̇O
2
 (P = 0.799) for exer-
cise initiated at 60% ∆ over PL was evident. There were no 
differences in V̇O
2b
 (P = 0.246), AV̇O
2
 (P = 0.427), TDV̇O
2
 
(P = 0.617), SCV̇O
2
 (P = 0.887) or end exercise V̇O
2
 
(P = 0.954) between conditions. TD
SCV̇O
2
 was lower fol-
lowing CF vs. PL supplementation (PL 110 ± 15 s vs. CF 
95 ± 13 s, P = 0.002). Both end-exercise V̇O
2
 (P = 0.959) 
and  Tlim (P = 0.480) were not significantly different follow-
ing PL and CF supplementation during severe-intensity 
exercise (see Table 2).
Table 1  Heart rate and blood lactate responses during moderate- and severe-intensity exercise following CF and PL supplementation
Values are mean ± SD 
HRb, baseline heart rate, AHR amplitude of the fundamental response, τHR time constant of the fundamental response, PL placebo, CF cocoa 
flavanol





τHR (s) End exercise 
HR (b  min−1)
Baseline blood 
lactate (mM)








 PL 83 ± 13 31 ± 8 53 ± 22 114 ± 16 1.5 ± 0.7 2.6 ± 0.5 1.2 ± 0.9 –
 CF 83 ± 14 32 ± 8 47 ± 13 115 ± 18 1.3 ± 0.4 2.5 ± 0.7 1.3 ± 0.8 –
Severe-intensity exercise
 PL 89 ± 15 69 ± 16 89 ± 17 159 ± 14 1.9 ± 0.9 8.8 ± 2.0 7.4 ± 2.5 9.5 ± 2.3#
 CF 92 ± 17 67 ± 17 89 ± 29 160 ± 17 1.8 ± 0.9 8.4 ± 2.3 7.1 ± 2.8 9.7 ± 1.9#
Table 2  Pulmonary  O2 uptake responses to moderate- and severe-intensity exercise following CF and PL supplementation
Values are mean ± SD 
V̇O
2b
 baseline oxygen uptake, AV̇O
2
 amplitude of the fundamental response, TDV̇O
2
 time delay of the fundamental response, 𝜏V̇O
2
 time con-
stant of the fundamental response, TD
SCV̇O
2
 time delay of the V̇O
2
 slow component, SCV̇O
2
 magnitude of the slow component, Tlim limit of exer-
cise tolerance, PL placebo, CF cocoa flavanol






















 PL 0.69 ± 0.12 0.77 ± 0.32 13 ± 6 40 ± 12 1.50 ± 0.35 – – –
 CF 0.66 ± 0.13 0.79 ± 0.34 13 ± 7 34 ± 9* 1.50 ± 0.38 – – –
Severe-intensity exercise
 PL 0.78 ± 0.14 1.40 ± 0. 40 17 ± 4 27 ± 9 2.60 ± 0.66 110 ± 15 0.50 ± 0.20 435 ± 58
 CF 0.74 ± 0.13 1.50 ± 0.52 16 ± 4 28 ± 6 2.60 ± 0.65 95 ± 13* 0.50 ± 0.20 424 ± 47
Fig. 3  Pulmonary V̇O
2
 and best-fit modelled responses of a represent-
ative participant to moderate-intensity exercise following PL (solid 
black circles) and CF (clear circles) supplementation. 𝜏V̇O
2
 values 
are displayed for each transition, with the solid grey lines represent-
ing the modelled fits
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Discussion
The purpose of this study was to examine the impact of 
CFs on pulmonary V̇O
2
 kinetics during two intensities 
of cycling exercise in healthy, normotensive middle-aged 
individuals. Congruent with our hypothesis, the major 
finding of this study was that 7-days CF supplementation 
sped pulmonary V̇O
2
 kinetics during moderate-intensity 
exercise as demonstrated by a significant reduction in 
𝜏V̇O
2
 . These effects of CFs, however, were not apparent 
during severe-intensity exercise when compared with a 
PL. Ultimately, the findings of the present study may have 
clinical potential in contributing to improved tolerance of 
daily life activity in middle-aged adults.
Effects of CFs on the physiological responses 
to moderate‑intensity exercise
This study is the first to investigate whether CFs modulate 
pulmonary V̇O
2
 kinetics. We show that 7 days CF supple-
mentation significantly reduced the 𝜏V̇O
2
 (40 s vs. 34 s) 
associated with the transition from unloaded to moderate-
intensity cycling in middle-aged adults. Notably, the mag-
nitude of change in 𝜏V̇O
2
 (~ 6 s) reported is important, as 
it exceeds the minimum physiologically relevant change of 
~ 5 s (Benson et al. 2017). The reduction in 𝜏V̇O
2
 observed 
after CF supplementation in our middle-aged individuals 
reflects a shift towards values typically observed in younger 
healthy individuals (Grassi et al. 2009), whereby V̇O
2
 kinet-
ics are not limited by  O2 delivery per se (Poole and Jones 
2012). Theoretically, a lowered 𝜏V̇O
2
 would reduce the 
 O2 deficit incurred during the exercise transition, thereby 
causing less perturbations to the intracellular milieu (i.e., 
∆ phosphocreatine, ADP,  H+, inorganic phosphate, glyco-
gen) and enhancing exercise tolerance (Grassi et al. 2011; 
Goulding et al. 2017, 2018). Therefore, our data suggest CFs 
may lower the  O2 deficit incurred during moderate-intensity 




Since the purpose of the study was to examine the impact 
of CFs on V̇O
2
 kinetics, our data raise the question about the 
potential underlying mechanisms contributing to the low-
ered 𝜏V̇O
2
 with CF supplementation. It is acknowledged 
𝜏V̇O
2
 is sensitive to manipulations in  O2 delivery (DeLo-
rey et al. 2004b; Gurd et al. 2009), and, that the slowing of 
V̇O
2
 kinetics with advancing age occurs at least partly as a 
consequence of lowered  O2 availability in oxidative skeletal 
muscle (DeLorey et al. 2004a; Musch et al. 2004; Behnke 
and Delp 2010). Given that CFs exert potent NO-dependent 
vasodilatory effects (Schroeter et al. 2006; Cifuentes-Gomez 
et al. 2015; Decroix et al. 2018a), CF supplementation may 
have sped V̇O
2
 kinetics by augmenting muscle blood flow 
and  O2 availability. Although, it is important to acknowledge 
CFs can alter indices of mitochondrial biogenesis and func-
tion (Taub et al. 2012; Kopustinskiene et al. 2015), as well 
as lower markers of oxidative stress (Ahmed et al. 2020). 
Together these factors may also influence V̇O
2
 responses 
to exercise by augmenting the capacity for  O2 utilsisation 
and delivery. Clearly, futher work is required to determine 




In spite of differences in the kinetics of V̇O
2
 , no changes 
in the  O2 cost of moderate-intensity exercise were observed 
after CF supplementation. Similarly, Patel et al. (2015) 
demonstrated no significant reduction in V̇O
2
 during twenty 
minutes of moderate-intensity cycling after 14 days dark 
chocolate supplementation (Patel et al. 2015). Together 
these findings contrast those published employing alternate 
Fig. 4  Pulmonary V̇O
2
 and best-fit modelled responses to severe-
intensity exercise following PL (solid black circles) and CF (clear 
black circles) supplementation. Panel a Pulmonary V̇O
2
 responses of 
a representative participant displayed with associated 𝜏V̇O
2
 . Panel b 
Group mean V̇O
2
 responses during the rest-to-exercise transition fol-
lowing PL and CF supplementation. Group mean ± SD V̇O
2
 at limit of 
exercise tolerance also shown. Solid grey lines represent the modelled 
fits
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dietary means of augmenting NO bioavailability, such as 
dietary nitrate, which reduces the  O2 cost of moderate-inten-
sity activity (Larsen et al. 2007; Bailey et al. 2009; Van-
hatalo et al. 2010; Lansley et al. 2011). Such discrepancies 
may be explained by recent evidence linking dietary nitrate 
to improved contractile function (Bailey et al. 2019), an 
effect that has not been reported with CF supplementation. 
Possibly, the mechanisms by which CFs impact physiologi-
cal responses to exercise relate to muscle  O2 delivery rather 
than contractile function. Given that we did not measure 
NO or redox biomarkers, it is not clear to what extent CFs 
sped phase II V̇O
2
 kinetics through processes associated with 
reactive  O2 and nitrogen species. Additional research will 
help delineate CFs mode of action in the context of exercise.
Effects of CFs on the physiological responses 
to severe‑intensity exercise
In contrast to our observations during moderate-intensity 
exercise, acute CF supplementation had no measurable 
impact on pulmonary V̇O
2
 kinetics during severe-intensity 
cycling. For instance, the 𝜏V̇O
2
 of the phase II response was 
similar between PL and CF (27 s vs. 28 s, respectively). The 
kinetics of V̇O
2
 are considered to be an important determi-
nant of exercise tolerance (Whipp and Ward 1992; Grassi 
et al. 2011). In line with this principle, we observed no effect 
of CF supplementation on  Tlim during severe-intensity exer-
cise. Whilst no previous studies have examined the impact of 
CF supplementation on V̇O
2
 kinetics in the severe-intensity 
exercise domain, a number have studied their effects on 
exercise performance. Our findings corroborate these data 
showing no beneficial impact of acute or sub-chronic CF 
supplementation on time-trial or time-to-exhaustion perfor-
mance in healthy male adults (Allgrove et al. 2011; Davison 
et al. 2012; Peschek et al. 2013; Stellingwerff et al. 2014; 
Decroix et al. 2018b).
Our data demonstrate divergent effects of CFs on V̇O
2
 
kinetics between moderate- and severe-intensity exercise 
domains. Given that the pattern of muscle-fibre activation 
within moderate- and severe-intensity exercise domains dif-
fers (type I and type II predominant, respectively) (Krus-
trup et al. 2004), future studies should investigate a potential 
muscle fibre-type dependency of CF supplementation on the 
physiological responses to exercise. Another potential expla-
nation for the differences between exercise intensity domains 
presented herein relates to the dose of CFs administered. 
Recent published evidence suggests that the 400 mg CF pre-
scribed is the minimum dose necessary to exert beneficial 
effects during exercise (Decroix et al. 2018a). Therefore, 
the dose used in the present study may not have been high 
enough to raise blood flow sufficiently to detect a measurable 
effect upon V̇O
2
 kinetics during severe-intensity exercise. In 
addition, CFs had no beneficial impact on resting systolic 
or diastolic blood pressure over PL, which may be attribut-
able to insufficient dosage and the normotensive population 
studied (Hooper et al. 2012). Besides, another limitation of 
the study is that only a single bout of severe-intensity exer-
cise was conducted. As we were unable to feasibly include 
additional visits for testing, we could not carry out multiple 
severe-intensity bouts to enhance the signal-to-noise ratio 
of these V̇O
2
 responses and potentially detect differences 
between conditions. Finally, it is possible that prior exercise, 
through its effects on (muscle) perfusion, sped the phase II 
V̇O
2
 kinetic response during severe-intensity exercise in the 
population studied (Scheuermann et al. 2002).
Conclusion
In the present study, seven days supplementation with a fla-
vanol-rich cocoa-extract resulted in a reduced 𝜏V̇O
2
 during 
moderate-, but not severe-intensity exercise in normotensive, 
middle-aged adults. Whilst the  O2 cost of exercise was simi-
lar between CF and PL conditions, the phase II V̇O
2
 kinet-
ics were sped at the onset of moderate-intensity exercise 
after acute CF intake. Such effects on phase II V̇O
2
 kinetics 
were not found during severe-intensity exercise with CF. 
Therefore, CF supplementation may reduce the metabolic 
perturbations associated with moderate-intensity exercise in 
middle-aged adults through speeding phase II V̇O
2
 kinetics.
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